Welcoming Jeremy Brody and Marisa Co to the Cornerstone AI Advisory Board

Healthcare's real bottleneck isn't technology. It's trust.

That's because healthcare is personal, it's all of us, as patients and as families. Trust isn't something you can announce or acquire. It compounds, decision by decision, over years, until it becomes something you can point to: a track record.

Today I'm proud to welcome two people whose track records speak for themselves. Jeremy Brody and Marisa Co are joining Cornerstone as advisors.

Jeremy Brody

Jeremy reached out a few years ago to grab coffee in New York. I knew him by reputation, more than twelve years as Chief Strategy Officer at Kantar Health and three decades shaping how the life sciences industry generates real-world evidence. If you work in healthcare, chances are you either know Jeremy or know someone who does. He's our industry's Kevin Bacon.

We stayed in touch, the conversations kept getting deeper, and eventually the obvious question was why his expertise wasn't formally in our corner. Jeremy now leads Brody Capital & Advisors, where he counsels operators, investors, and pharma leaders across the RWD and clinical trial ecosystem. He has a real pulse on the market and clear opinions about what's durable and what's hype.

And perhaps most importantly, he's a great human. I'm thrilled to have him with us.

Marisa Co

I had the privilege of partnering with Marisa during my time at COTA, where we worked together to advance blood cancer research. That work built admiration and mutual respect that have only grown since.

Marisa has spent her career at the intersection of data, analytics, and innovation in life sciences, including senior roles at Amgen and NRI before serving as VP of Real-World Data Analytics, Innovation & Partnerships at Bristol Myers Squibb. She saw the manual data-quality problem firsthand — her teams losing cycles to work that should have been automated — and she championed a better way long before the industry caught up. That conviction later made the partnership between BMS and Cornerstone a natural one.

Great leaders build leaders, and Marisa is proof. I've worked directly with several leaders who came up on her teams, and you can see her fingerprints on how they operate: rigorous, empathetic, and unafraid to think big. Today she leads InnovationEdge LLC, advising life sciences companies and serving on boards across the industry, and I couldn't be more excited to welcome her to our advisory board.

Few people have seen this problem from the buyer's chair, the builder's chair, and the boardroom. Marisa makes you dream big — and then works side by side with you in making that vision real.

Why this matters

Cornerstone is at the point in its arc where the surface area is expanding fast, which data domains to sequence next, where to partner versus build, how to serve pharma at scale without losing the rigor that got us here. Jeremy and Marisa have lived these questions from both sides of the table. Their counsel will sharpen how we make these calls.

Jeremy and Marisa: thank you. The work is just getting started.

‍